{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:24Z","timestamp":1786979964465,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00296-019-04408-3","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T07:10:08Z","timestamp":1564729808000},"page":"1741-1748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Malignancy risk in Korean male patients with ankylosing spondylitis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0215-3855","authenticated-orcid":false,"given":"Bora","family":"Nam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-461X","authenticated-orcid":false,"given":"Hyoungyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-9815","authenticated-orcid":false,"given":"Eun Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-8837","authenticated-orcid":false,"given":"Soo-Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8939","authenticated-orcid":false,"given":"Yoon-Kyoung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-2276","authenticated-orcid":false,"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"issue":"9570","key":"4408_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379\u20131390. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"issue":"9255","key":"4408_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to virchow? Lancet 357(9255):539\u2013545. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(00)04046-0","journal-title":"Lancet"},{"issue":"6917","key":"4408_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867. \n                    https:\/\/doi.org\/10.1038\/nature01322","journal-title":"Nature"},{"key":"4408_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1370","author":"LL Munn","year":"2017","unstructured":"Munn LL (2017) Cancer and inflammation. Wiley Interdiscip Rev Syst Biol Med. \n                    https:\/\/doi.org\/10.1002\/wsbm.1370","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"2","key":"4408_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","volume":"42","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lin F, Qin B, Liang Y, Zhong R (2015) Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol 42(2):282\u2013291. \n                    https:\/\/doi.org\/10.3899\/jrheum.140566","journal-title":"J Rheumatol"},{"key":"4408_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","volume":"17","author":"TA Simon","year":"2015","unstructured":"Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17:212. \n                    https:\/\/doi.org\/10.1186\/s13075-015-0728-9","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4408_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","volume":"65","author":"A Onishi","year":"2013","unstructured":"Onishi A, Sugiyama D, Kumagai S, Morinobu A (2013) Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65(7):1913\u20131921. \n                    https:\/\/doi.org\/10.1002\/art.37969","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4408_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","volume":"73","author":"Y Liang","year":"2014","unstructured":"Liang Y, Yang Z, Qin B, Zhong R (2014) Primary Sjogren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis 73(6):1151\u20131156. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-203305","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4408_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/ard.2002.004721","volume":"62","author":"N Feltelius","year":"2003","unstructured":"Feltelius N, Ekbom A, Blomqvist P (2003) Cancer incidence among patients with ankylosing spondylitis in Sweden 1965\u201395: a population based cohort study. Ann Rheum Dis 62(12):1185\u20131188","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4408_CR10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1136\/ard.2005.047514","volume":"65","author":"J Askling","year":"2006","unstructured":"Askling J, Klareskog L, Blomqvist P, Fored M, Feltelius N (2006) Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis 65(9):1184\u20131187. \n                    https:\/\/doi.org\/10.1136\/ard.2005.047514","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4408_CR11","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/art.38339","volume":"66","author":"K Hellgren","year":"2014","unstructured":"Hellgren K, Smedby KE, Backlin C, Sundstrom C, Feltelius N, Eriksson JK, Baecklund E, Askling J (2014) Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Arthritis Rheumatol 66(5):1282\u20131290. \n                    https:\/\/doi.org\/10.1002\/art.38339","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"4408_CR12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3892\/ol.2017.6368","volume":"14","author":"CC Chang","year":"2017","unstructured":"Chang CC, Chang CW, Nguyen PA, Chang TH, Shih YL, Chang WY, Horng JT, Lee OK, Ho JH (2017) Ankylosing spondylitis and the risk of cancer. Oncol Lett 14(2):1315\u20131322. \n                    https:\/\/doi.org\/10.3892\/ol.2017.6368","journal-title":"Oncol Lett"},{"issue":"5","key":"4408_CR13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","volume":"32","author":"JA Kim","year":"2017","unstructured":"Kim JA, Yoon S, Kim LY, Kim DS (2017) Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci 32(5):718\u2013728. \n                    https:\/\/doi.org\/10.3346\/jkms.2017.32.5.718","journal-title":"J Korean Med Sci"},{"key":"4408_CR14","doi-asserted-by":"publisher","first-page":"e2014008","DOI":"10.4178\/epih\/e2014008","volume":"36","author":"L Kim","year":"2014","unstructured":"Kim L, Kim JA, Kim S (2014) A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health 36:e2014008. \n                    https:\/\/doi.org\/10.4178\/epih\/e2014008","journal-title":"Epidemiol Health"},{"issue":"2","key":"4408_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4143\/crt.2018.143","volume":"50","author":"KW Jung","year":"2018","unstructured":"Jung KW, Won YJ, Kong HJ, Lee ES, Community of Population-Based Regional Cancer R (2018) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat 50(2):303\u2013316. \n                    https:\/\/doi.org\/10.4143\/crt.2018.143","journal-title":"Cancer Res Treat"},{"key":"4408_CR16","doi-asserted-by":"publisher","first-page":"32063","DOI":"10.1038\/srep32063","volume":"6","author":"C Deng","year":"2016","unstructured":"Deng C, Li W, Fei Y, Li Y, Zhang F (2016) Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis. Sci Rep 6:32063. \n                    https:\/\/doi.org\/10.1038\/srep32063","journal-title":"Sci Rep"},{"issue":"1","key":"4408_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.berh.2016.03.001","volume":"30","author":"G Egiziano","year":"2016","unstructured":"Egiziano G, Bernatsky S, Shah AA (2016) Cancer and autoimmunity: harnessing longitudinal cohorts to probe the link. Best Pract Res Clin Rheumatol 30(1):53\u201362. \n                    https:\/\/doi.org\/10.1016\/j.berh.2016.03.001","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"4408_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semarthrit.2007.01.002","volume":"37","author":"J Llorca","year":"2007","unstructured":"Llorca J, Lopez-Diaz MJ, Gonzalez-Juanatey C, Ollier WE, Martin J, Gonzalez-Gay MA (2007) Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain. Semin Arthritis Rheum 37(1):31\u201338. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2007.01.002","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"4408_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","volume":"88","author":"E Baimpa","year":"2009","unstructured":"Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88(5):284\u2013293. \n                    https:\/\/doi.org\/10.1097\/MD.0b013e3181b76ab5","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4408_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3899\/jrheum.110754","volume":"39","author":"C Baldini","year":"2012","unstructured":"Baldini C, Pepe P, Luciano N, Ferro F, Talarico R, Grossi S, Tavoni A, Bombardieri S (2012) A clinical prediction rule for lymphoma development in primary Sjogren\u2019s syndrome. J Rheumatol 39(4):804\u2013808. \n                    https:\/\/doi.org\/10.3899\/jrheum.110754","journal-title":"J Rheumatol"},{"issue":"7","key":"4408_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJM198208123070718","volume":"307","author":"M Alcalay","year":"1982","unstructured":"Alcalay M, Bontoux D, Maire P, Matuchansky C, Alcalay D, Tanzer J (1982) HLA-B27 and colorectal cancer. N Engl J Med 307(7):443\u2013444. \n                    https:\/\/doi.org\/10.1056\/NEJM198208123070718","journal-title":"N Engl J Med"},{"issue":"2","key":"4408_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1365-2141.2001.03114.x","volume":"115","author":"WY Au","year":"2001","unstructured":"Au WY, Hawkins BR, Cheng N, Lie AK, Liang R, Kwong YL (2001) Risk of haematological malignancies in HLA-B27 carriers. Br J Haematol 115(2):320\u2013322","journal-title":"Br J Haematol"},{"issue":"3","key":"4408_CR23","first-page":"262","volume":"43","author":"RE Hammer","year":"1995","unstructured":"Hammer RE, Richardson JA, Simmons WA, White AL, Breban M, Taurog JD (1995) High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease. J Investig Med 43(3):262\u2013268","journal-title":"J Investig Med"},{"issue":"3","key":"4408_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djm323","volume":"100","author":"H Endogenous","year":"2008","unstructured":"Endogenous H, Prostate Cancer Collaborative G, Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100(3):170\u2013183. \n                    https:\/\/doi.org\/10.1093\/jnci\/djm323","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4408_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2559.2011.04007.x","volume":"60","author":"DG Bostwick","year":"2012","unstructured":"Bostwick DG, Cheng L (2012) Precursors of prostate cancer. Histopathology 60(1):4\u201327. \n                    https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04007.x","journal-title":"Histopathology"},{"issue":"4","key":"4408_CR26","first-page":"171","volume":"6","author":"DG Bostwick","year":"2004","unstructured":"Bostwick DG, Liu L, Brawer MK, Qian J (2004) High-grade prostatic intraepithelial neoplasia. Rev Urol 6(4):171\u2013179","journal-title":"Rev Urol"},{"issue":"13","key":"4408_CR27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","volume":"362","author":"GL Andriole","year":"2010","unstructured":"Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS, Group RS (2010) Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362(13):1192\u20131202. \n                    https:\/\/doi.org\/10.1056\/nejmoa0908127","journal-title":"N Engl J Med"},{"issue":"6 Suppl 28","key":"4408_CR28","first-page":"S52","volume":"20","author":"RH Straub","year":"2002","unstructured":"Straub RH, Struharova S, Scholmerich J, Harle P (2002) No alterations of serum levels of adrenal and gonadal hormones in patients with ankylosing spondylitis. Clin Exp Rheumatol 20(6 Suppl 28):S52\u2013S59","journal-title":"Clin Exp Rheumatol"},{"key":"4408_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fonc.2018.00437","volume":"8","author":"Z Shang","year":"2018","unstructured":"Shang Z, Wang X, Yan H, Cui B, Wang Q, Wu J, Cui X, Li J, Ou T, Yang K (2018) Intake of non-steroidal anti-inflammatory drugs and the risk of prostate cancer: a meta-analysis. Front Oncol 8:437. \n                    https:\/\/doi.org\/10.3389\/fonc.2018.00437","journal-title":"Front Oncol"},{"issue":"10039","key":"4408_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet 388(10039):73\u201385. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)00141-0","journal-title":"Lancet"},{"issue":"3","key":"4408_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","volume":"20","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Baeten D (2006) Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 20(3):451\u2013471. \n                    https:\/\/doi.org\/10.1016\/j.berh.2006.03.010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"4408_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","volume":"19","author":"MW Lutgens","year":"2013","unstructured":"Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B (2013) Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 19(4):789\u2013799. \n                    https:\/\/doi.org\/10.1097\/MIB.0b013e31828029c0","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"4408_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","volume":"146","author":"A Rostom","year":"2007","unstructured":"Rostom A, Dube C, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D, Force USPST (2007) Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the US Preventive Services Task Force. Ann Intern Med 146(5):376\u2013389","journal-title":"Ann Intern Med"},{"issue":"9573","key":"4408_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","volume":"369","author":"E Flossmann","year":"2007","unstructured":"Flossmann E, Rothwell PM, British Doctors Aspirin T, The UKTIAAT (2007) Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369(9573):1603\u20131613. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(07)60747-8","journal-title":"Lancet"},{"issue":"9","key":"4408_CR35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1056\/NEJMoa061355","volume":"355","author":"MM Bertagnolli","year":"2006","unstructured":"Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET, Investigators APCS (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355(9):873\u2013884. \n                    https:\/\/doi.org\/10.1056\/NEJMoa061355","journal-title":"N Engl J Med"},{"issue":"18","key":"4408_CR36","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1200\/JCO.2009.26.0695","volume":"28","author":"CY Wu","year":"2010","unstructured":"Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT (2010) Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol 28(18):2952\u20132957. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.26.0695","journal-title":"J Clin Oncol"},{"issue":"7","key":"4408_CR37","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s10620-014-3056-z","volume":"59","author":"NE Burr","year":"2014","unstructured":"Burr NE, Talboys RJ, Savva S, Clark A, Phillips M, Metcalfe M, Dennison A, Robinson R, Lewis MP, Rhodes M, Rushbrook S, Hart AR (2014) Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom. Dig Dis Sci 59(7):1567\u20131572. \n                    https:\/\/doi.org\/10.1007\/s10620-014-3056-z","journal-title":"Dig Dis Sci"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04408-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T05:17:11Z","timestamp":1596259031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04408-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4408"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04408-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"16 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"To protect patient privacy, the National Health Insurance (NHI) stores beneficiary identifications in an encrypted format and provides data to the public without individual identifiers. Using these data allowed our study to be included in exemption categories (Institutional Review Board file no. HYUH 2018-12-027).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}